State of New Jersey Common Pension Fund D Reduces Holdings in Danaher Corporation $DHR

State of New Jersey Common Pension Fund D lessened its position in shares of Danaher Corporation (NYSE:DHR) by 0.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 218,311 shares of the conglomerate’s stock after selling 425 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Danaher were worth $43,125,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. MGO One Seven LLC lifted its position in shares of Danaher by 485.7% during the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate’s stock valued at $5,145,000 after buying an additional 20,813 shares during the last quarter. Chicago Capital LLC lifted its holdings in Danaher by 11.6% during the 2nd quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate’s stock worth $2,634,000 after purchasing an additional 1,391 shares in the last quarter. UniSuper Management Pty Ltd lifted its holdings in Danaher by 1.6% during the 1st quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate’s stock worth $34,954,000 after purchasing an additional 2,667 shares in the last quarter. Asahi Life Asset Management CO. LTD. purchased a new stake in Danaher during the 1st quarter worth about $539,000. Finally, Horizon Financial Services LLC lifted its holdings in Danaher by 20,400.0% during the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate’s stock worth $1,681,000 after purchasing an additional 8,160 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the topic of a number of recent research reports. Evercore ISI increased their price objective on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Wells Fargo & Company reissued a “positive” rating on shares of Danaher in a report on Thursday. JPMorgan Chase & Co. increased their price objective on Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a report on Wednesday. Deutsche Bank Aktiengesellschaft upped their target price on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, Bank of America decreased their target price on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research note on Monday, September 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $243.39.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 11.10% of the stock is owned by corporate insiders.

Danaher Price Performance

Shares of Danaher stock opened at $223.03 on Friday. The company has a current ratio of 1.52, a quick ratio of 1.22 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $157.54 billion, a PE ratio of 45.99, a price-to-earnings-growth ratio of 3.41 and a beta of 0.77. The business’s 50-day moving average price is $202.73 and its 200-day moving average price is $198.36. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.The company’s revenue was up 4.4% on a year-over-year basis. During the same period in the prior year, the company earned $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date is Friday, September 26th. This represents a $1.28 annualized dividend and a yield of 0.6%. Danaher’s dividend payout ratio is currently 26.39%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.